H K Nieuwenhuis
Overview
Explore the profile of H K Nieuwenhuis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Donker A, Raymakers R, Nieuwenhuis H, Coenen M, Janssen M, MacKenzie M, et al.
Neth J Med
. 2014 May;
72(4):210-7.
PMID: 24829177
Background: X-linked sideroblastic anaemia (XLSA; OMIM#300751) is the most common inherited form of sideroblastic anaemia and is associated with several mutations in the erythroid specific 5-aminolevulinate synthase gene (ALAS₂). This...
2.
Buijs A, Poot M, van der Crabben S, Van Der Zwaag B, van Binsbergen E, van Roosmalen M, et al.
Leukemia
. 2012 Mar;
26(9):2151-4.
PMID: 22430633
No abstract available.
3.
Escolar G, Rao G, Nieuwenhuis H, White J
Platelets
. 2010 Nov;
7(5-6):297-301.
PMID: 21043665
P-selectin is an alpha granule membrane associated glycoprotein in platelets (P1) expressed on the surface following exposure to secretagogues in suspension. It is not clear, whether P-selectin is transported from...
4.
Meijer E, Dekker A, Lokhorst H, Petersen E, Nieuwenhuis H, Verdonck L
Transpl Infect Dis
. 2005 Mar;
6(4):171-8.
PMID: 15762935
Allogeneic stem cell transplantation (SCT) using a myeloablative (MA) conditioning regimen is limited to relatively young patients because of increased transplant-related mortality in elderly patients. Nonmyeloablative (NMA) conditioning regimens have...
5.
Lisman T, Bijsterveld N, Adelmeijer J, Meijers J, Levi M, Nieuwenhuis H, et al.
J Thromb Haemost
. 2003 Nov;
1(11):2368-73.
PMID: 14629471
Background: Fondaparinux is a synthetic pentasaccharide, which selectively inhibits coagulation factor (F) Xa, and is registered for prevention of venous thromboembolism following hip fracture, hip replacement, and knee replacement surgery....
6.
Schutgens R, Haas F, Gerritsen W, van der Horst F, Nieuwenhuis H, Biesma D
J Thromb Haemost
. 2003 Jul;
1(5):976-81.
PMID: 12871364
D-Dimer measurement is a promising tool in the exclusion of venous thrombosis. New d-dimer assays have been introduced, but need clinical validation. Our objective was to evaluate the clinical usefulness...
7.
Schutgens R, Ackermark P, Haas F, Nieuwenhuis H, Peltenburg H, Pijlman A, et al.
Circulation
. 2003 Feb;
107(4):593-7.
PMID: 12566372
Background: Serial ultrasonography is reliable for the diagnosis of deep venous thrombosis in symptomatic patients, but the low prevalence of thrombosis in this group renders the approach costly and inconvenient...
8.
Fijnheer R, Urbanus R, Nieuwenhuis H
Ned Tijdschr Geneeskd
. 2003 Feb;
147(1):21-5.
PMID: 12564293
Acetylsalicylic acid (aspirin) induces an irreversible inactivation of cyclo-oxygenase in blood platelets which lasts for the entire period that the platelets remain in the circulatory system, 7 to 10 days....
9.
De Vooght K, van Wijk R, Nieuwenhuis H, Ploos van Amstel J, Rijksen G, van Solinge W
Ned Tijdschr Geneeskd
. 2002 Oct;
146(39):1828-31.
PMID: 12382367
Pyruvate kinase (PK) deficiency is a common cause of hereditary non-spherocytic haemolytic anaemia. It is an autosomal recessive disorder caused by mutations in the gene coding for erythrocyte and liver-type...
10.
Mosnier L, Lisman T, van den Berg H, Nieuwenhuis H, Meijers J, Bouma B
Thromb Haemost
. 2001 Nov;
86(4):1035-9.
PMID: 11686321
TAFI (thrombin activatable fibrinolysis inhibitor) down regulates fibrinolysis after activation by relatively high concentrations of thrombin generated during coagulation via thrombin mediated factor XI activation and subsequent activation of the...